Barry R Davies

Summary

Affiliation: University of Newcastle
Country: UK

Publications

  1. ncbi Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFalpha transgenic rats
    B R Davies
    Department of Surgery, School of Surgical Sciences, The Medical School, University of Newcastle upon Tyne, Cambridge, United Kingdom
    Am J Pathol 155:303-14. 1999
  2. ncbi Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer
    Barry R Davies
    Department of Surgery, The Medical School, University of Newcastle, Newcastle upon Tyne NE2 4HH, UK
    J Pathol 196:292-9. 2002
  3. ncbi Gene products involved in metastasis of bladder cancer
    B R Davies
    Northern Institute for Cancer Research, and School of Surgical and Reproductive Sciences, The Medical School, University of Newcastle, Newcastle upon Tyne, UK
    Histol Histopathol 18:969-80. 2003
  4. ncbi Immortalisation of human ovarian surface epithelium with telomerase and temperature-sensitive SV40 large T antigen
    Barry R Davies
    Department of Surgery, University of Newcastle, Newcastle upon Tyne, NE2 4HH, UK
    Exp Cell Res 288:390-402. 2003
  5. ncbi Ligands to FGF receptor 2-IIIb induce proliferation, motility, protection from cell death and cytoskeletal rearrangements in epithelial ovarian cancer cell lines
    Islay A Steele
    Northern Institute for Cancer Research and School of Surgical and Reproductive Sciences, Faculty of Medical Sciences, University of Newcastle, Newcastle-upon-Tyne, UK
    Growth Factors 24:45-53. 2006
  6. ncbi Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancer
    Diana Levett
    Department of Surgery, The Medical School, University of Newcastle-upon-Tyne, Newcastle NE2 4HH, United Kingdom
    Am J Pathol 160:693-700. 2002
  7. ncbi High-mobility group protein 1(Y): metastasis-associated or metastasis-inducing?
    Alice Evans
    School of Surgical and Reproductive Sciences and Northern Institute for Cancer Research, Faculty of Medical Sciences, University of Newcastle upon Tyne, United Kingdom
    J Surg Oncol 88:86-99. 2004
  8. ncbi Behavioural assessment of the effects of tumour growth in rats and the influence of the analgesics carprofen and meloxicam
    John V Roughan
    Comparative Biology Centre, The Medical School, University of Newcastle, Newcastle upon Tyne, NE2 4HH, UK
    Lab Anim 38:286-96. 2004
  9. ncbi Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy
    Pallavi Mehrotra
    School of Surgical and Reproductive Sciences, Department of Cellular Pathology, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom
    Laryngoscope 116:1434-8. 2006
  10. ncbi Celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma
    Simon J Dovedi
    Department of Surgery Northern Institute for Cancer Research, Medical School, University of Newcastle, Newcastle upon Tyne, United Kingdom
    Eur Urol 54:621-30. 2008

Collaborators

Detail Information

Publications12

  1. ncbi Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFalpha transgenic rats
    B R Davies
    Department of Surgery, School of Surgical Sciences, The Medical School, University of Newcastle upon Tyne, Cambridge, United Kingdom
    Am J Pathol 155:303-14. 1999
    ..These transgenic rat models confirm the conclusions reached in transgenic mice that overexpression of the c-erbB-2 and TGFalpha genes predisposes the mammary gland to stochastic tumor development...
  2. ncbi Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer
    Barry R Davies
    Department of Surgery, The Medical School, University of Newcastle, Newcastle upon Tyne NE2 4HH, UK
    J Pathol 196:292-9. 2002
    ..0001). It is concluded that S100A4 expression may play an important role in bladder cancer and may identify a subgroup of patients at increased risk of metastasis who should be considered for adjuvant systemic therapy...
  3. ncbi Gene products involved in metastasis of bladder cancer
    B R Davies
    Northern Institute for Cancer Research, and School of Surgical and Reproductive Sciences, The Medical School, University of Newcastle, Newcastle upon Tyne, UK
    Histol Histopathol 18:969-80. 2003
    ....
  4. ncbi Immortalisation of human ovarian surface epithelium with telomerase and temperature-sensitive SV40 large T antigen
    Barry R Davies
    Department of Surgery, University of Newcastle, Newcastle upon Tyne, NE2 4HH, UK
    Exp Cell Res 288:390-402. 2003
    ..OSE-C2 cells may be useful in studying the physiology and differentiation of human OSE cells and provide insight into the poorly understood earliest stages of epithelial ovarian cancer...
  5. ncbi Ligands to FGF receptor 2-IIIb induce proliferation, motility, protection from cell death and cytoskeletal rearrangements in epithelial ovarian cancer cell lines
    Islay A Steele
    Northern Institute for Cancer Research and School of Surgical and Reproductive Sciences, Faculty of Medical Sciences, University of Newcastle, Newcastle-upon-Tyne, UK
    Growth Factors 24:45-53. 2006
    ..It is suggested that ligands to FGF receptor 2-IIIb affect a range of phenotypes important in the neoplastic growth of EOCs...
  6. ncbi Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancer
    Diana Levett
    Department of Surgery, The Medical School, University of Newcastle-upon-Tyne, Newcastle NE2 4HH, United Kingdom
    Am J Pathol 160:693-700. 2002
    ....
  7. ncbi High-mobility group protein 1(Y): metastasis-associated or metastasis-inducing?
    Alice Evans
    School of Surgical and Reproductive Sciences and Northern Institute for Cancer Research, Faculty of Medical Sciences, University of Newcastle upon Tyne, United Kingdom
    J Surg Oncol 88:86-99. 2004
    ..This may represent a potential therapeutic target for patients. The following review summarizes and critically appraises the evidence for the role of HMG-1(Y) in metastasis...
  8. ncbi Behavioural assessment of the effects of tumour growth in rats and the influence of the analgesics carprofen and meloxicam
    John V Roughan
    Comparative Biology Centre, The Medical School, University of Newcastle, Newcastle upon Tyne, NE2 4HH, UK
    Lab Anim 38:286-96. 2004
    ..More intensive behaviour monitoring may help to develop a suitable technique for detecting the onset of, and assess the severity of pain that may occur during tumour development...
  9. ncbi Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy
    Pallavi Mehrotra
    School of Surgical and Reproductive Sciences, Department of Cellular Pathology, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom
    Laryngoscope 116:1434-8. 2006
    ..CONCLUSION: Neither Mcm-2 or Ki-67 can currently be reliably applied as preoperative markers to distinguish benign from malignant thyroid lesions...
  10. ncbi Celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma
    Simon J Dovedi
    Department of Surgery Northern Institute for Cancer Research, Medical School, University of Newcastle, Newcastle upon Tyne, United Kingdom
    Eur Urol 54:621-30. 2008
    ....
  11. ncbi Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer
    Jose L Dominguez-Escrig
    Northern Institute for Cancer Research, School of Surgical and Reproductive Sciences, Faculty of Medical Sciences, University of Newcastle, Newcastle-upon-Tyne, United Kingdom
    Clin Cancer Res 10:4874-84. 2004
    ..It is likely that optimized therapy approaches will require an accurate "molecular" diagnosis allowing effective, selective, tailored therapeutic strategies to be designed...
  12. ncbi Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer
    Arezoo Astanehe
    Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada
    J Cell Sci 121:664-74. 2008
    ....